STOCKHOLM, Sept. 16,
2024 /PRNewswire/ -- Nasdaq Stockholm has decided that Calliditas
Therapeutics AB (publ) will be delisted from Nasdaq Stockholm. The
last day of trading in the share will be on Thursday, October 10, 2024.
For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency
of the contact person set out above, on September 16, 2024 at 15:30 CET.
About Calliditas
Calliditas Therapeutics is a biopharma company headquartered in
Stockholm, Sweden, focused on
identifying, developing, and commercializing novel treatments in
orphan indications with significant unmet medical needs.
Calliditas' common shares are listed on Nasdaq Stockholm (ticker:
CALTX). Visit Calliditas.com for further information.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/calliditas-therapeutics/r/delisting-of-calliditas-therapeutics-ab--publ--from-nasdaq-stockholm,c4038098
The following files are available for download:
|
https://mb.cision.com/Main/16574/4038098/3002835.pdf
|
Calliditas- announcing
date for de-listing (eng)
|
View original
content:https://www.prnewswire.com/news-releases/delisting-of-calliditas-therapeutics-ab-publ-from-nasdaq-stockholm-302249090.html
SOURCE Calliditas Therapeutics